Related references
Note: Only part of the references are listed.Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours
N. Rajan et al.
ONCOGENE (2011)
FOXE1 is a target for aberrant methylation in cutaneous squamous cell carcinoma
I. Venza et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Image-processing chain for a three-dimensional reconstruction of basal cell carcinomas
Patrick Scheibe et al.
EXPERIMENTAL DERMATOLOGY (2010)
Loss of the Tumor Suppressor CYLD Enhances Wnt/β-Catenin Signaling through K63-Linked Ubiquitination of Dvl
Daniele V. F. Tauriello et al.
MOLECULAR CELL (2010)
Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development
W-L Yang et al.
ONCOGENE (2010)
A System-Wide Investigation of the Dynamics of Wnt Signaling Reveals Novel Phases of Transcriptional Regulation
Taranjit S. Gujral et al.
PLOS ONE (2010)
Tumor Mapping in 2 Large Multigenerational Families With CYLD Mutations
Neil Rajan et al.
ARCHIVES OF DERMATOLOGY (2009)
LEF-1 expression in basal cell carcinomas
L. Kriegl et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Wnt Antagonist Gene DKK2 Is Epigenetically Silenced and Inhibits Renal Cancer Progression through Apoptotic and Cell Cycle Pathways
Hiroshi Hirata et al.
CLINICAL CANCER RESEARCH (2009)
Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
H. Suzuki et al.
BRITISH JOURNAL OF CANCER (2008)
Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines
Jaehyouk Lee et al.
GYNECOLOGIC ONCOLOGY (2008)
The tumor suppressor CYLD regulates microtubule dynamics and plays a role in cell migration
Jinmin Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module
David Komander et al.
MOLECULAR CELL (2008)
Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/beta-catenin signaling
Steven Hoseong Yang et al.
NATURE GENETICS (2008)
CYLD mutations in familial skin appendage tumours
S. Saggar et al.
JOURNAL OF MEDICAL GENETICS (2008)
Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors
Hironobu Sato et al.
CARCINOGENESIS (2007)
IKKα shields 14-3-3σ, a G2/M cell cycle checkpoint gene, from hypermethylation, preventing its silencing
Feng Zhu et al.
MOLECULAR CELL (2007)
WNT signaling pathway and stem cell signaling network
Masuko Katoh et al.
CLINICAL CANCER RESEARCH (2007)
Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses
William W. Reiley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
The tumor suppressor CYLD regulates entry into mitosis
Frank Stegmeier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
WNT and DKK determine hair follicle spacing through a reaction-diffusion mechanism
Stefanie Sick et al.
SCIENCE (2006)
TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD
Alexander Stokes et al.
CELLULAR SIGNALLING (2006)
Essential role of TAK1 in thymocyte development and activation
Hong-Hsing Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer
O. Aguilera et al.
ONCOGENE (2006)
Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-κB signaling
Ramin Massoumi et al.
CELL (2006)
Regulation of T cell development by the deubiquitinating enzyme CYLD
WW Reiley et al.
NATURE IMMUNOLOGY (2006)
Negative regulation of JNK signaling by the tumor suppressor CYLD
W Reiley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Analysis of 14-3-3σ expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma
D Lodygin et al.
ONCOGENE (2003)
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
TR Brummelkamp et al.
NATURE (2003)
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
A Kovalenko et al.
NATURE (2003)
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
E Trompouki et al.
NATURE (2003)
Wnt/β-catenin signaling induces the expression and activity of βTrCP ubiquitin ligase receptor
VS Spiegelman et al.
MOLECULAR CELL (2000)
Share Paper
